Vatanara et al., 2009 - Google Patents
Precipitation of fluticasone propionate microparticles using supercritical antisolventVatanara et al., 2009
View PDF- Document ID
- 55528624569656827
- Author
- Vatanara A
- ROUH A
- Gilani K
- Asgharian R
- Darabi M
- RAFIEI T
- Publication year
External Links
Snippet
Background: The ability of supercritical fluids (SCFs), such as carbon dioxide, to dissolve and expand or extract organic solvents and as result lower their solvation power, makes it possible the use of SCFs for the precipitation of solids from organic solutions. The process …
- 229960000289 fluticasone propionate 0 title abstract description 52
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1682—Processes
- A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Pasquali et al. | Supercritical fluid technologies: an innovative approach for manipulating the solid-state of pharmaceuticals | |
Kumar et al. | Various techniques for solubility enhancement: An overview | |
Pasquali et al. | Solid-state chemistry and particle engineering with supercritical fluids in pharmaceutics | |
JP3839042B2 (en) | Salmeterol xinafoate with sized particles | |
Kankala et al. | Supercritical fluid (SCF)-assisted fabrication of carrier-free drugs: an eco-friendly welcome to active pharmaceutical ingredients (APIs) | |
Kaur et al. | Improvement of drug solubility using solid dispersion | |
O'Sullivan et al. | Solid-state and particle size control of pharmaceutical cocrystals using atomization-based techniques | |
Tenorio et al. | Controlled submicro particle formation of ampicillin by supercritical antisolvent precipitation | |
Du et al. | Supercritical fluid assisted atomization introduced by an enhanced mixer for micronization of lysozyme: particle morphology, size and protein stability | |
Li et al. | Process parameters and morphology in puerarin, phospholipids and their complex microparticles generation by supercritical antisolvent precipitation | |
Corrigan et al. | Physicochemical and in vitro deposition properties of salbutamol sulphate/ipratropium bromide and salbutamol sulphate/excipient spray dried mixtures for use in dry powder inhalers | |
US8241371B2 (en) | Method of creating crystalline substances | |
Kale et al. | A Review on: Solubility Enhancement Techniques. | |
Adeli | The use of spray freeze drying for dissolution and oral bioavailability improvement of Azithromycin | |
Carr et al. | Particle formation of budesonide from alcohol-modified subcritical water solutions | |
MXPA05006441A (en) | Preparation of sterile aqueous suspensions comprising micronised crystalline active ingredients for inhalation. | |
Steckel et al. | Metered-dose inhaler formulation of fluticasone-17-propionate micronized with supercritical carbon dioxide using the alternative propellant HFA-227 | |
Vatanara et al. | A Plackett–Burman design for screening of the operation variables in the formation of salbutamol sulphate particles by supercritical antisolvent | |
Godse et al. | Techniques for solubility enhancement of Hydrophobic drugs: A Review | |
Vatanara et al. | Precipitation of fluticasone propionate microparticles using supercritical antisolvent | |
CA2905542C (en) | Methods and systems for conditioning of particulate crystalline materials | |
Xu et al. | Preparation of high-performance ultrafine budesonide particles for pulmonary drug delivery | |
Muhammad et al. | A novel method for the production of crystalline micronised particles | |
Chang et al. | Micronization of aztreonam with supercritical anti-solvent process | |
Foster et al. | Particle engineering by dense gas technologies applied to pharmaceuticals |